CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan FibroGen, Inc - FGEN CFD

    18.54
    2.68%
    0.30
    Rendah: 18.54
    Tinggi: 19.03
    Market Trading Hours* (UTC) Opens on Wednesday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.30
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.025457%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.003235%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    FibroGen Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    Key Stats
    Prev. Close* 19.05
    Open* 18.87
    1-Year Change* 89.65%
    Day's Range* 18.54 - 19.03
    52 wk Range 8.67-25.69
    Average Volume (10 days) 1.03M
    Average Volume (3 months) 18.80M
    Market Cap 1.87B
    P/E Ratio -100.00K
    Shares Outstanding 97.58M
    Revenue 116.07M
    EPS -3.27
    Dividend (Yield %) N/A
    Beta 0.79
    Next Earnings Date Aug 7, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 6, 2023 18.54 -0.46 -2.42% 19.00 19.14 18.53
    Jun 5, 2023 19.05 1.83 10.63% 17.22 19.43 17.22
    Jun 2, 2023 17.79 -0.94 -5.02% 18.73 19.05 17.34
    Jun 1, 2023 17.18 0.22 1.30% 16.96 17.59 16.70
    May 31, 2023 17.16 0.15 0.88% 17.01 17.61 16.72
    May 30, 2023 17.04 0.47 2.84% 16.57 17.33 16.46
    May 26, 2023 16.65 0.03 0.18% 16.62 16.80 16.33
    May 25, 2023 16.82 0.16 0.96% 16.66 16.91 16.44
    May 24, 2023 16.90 -0.05 -0.29% 16.95 17.33 16.51
    May 23, 2023 17.27 0.06 0.35% 17.21 18.03 16.99
    May 22, 2023 17.16 -0.14 -0.81% 17.30 18.02 16.96
    May 19, 2023 17.49 -0.07 -0.40% 17.56 18.07 17.20
    May 18, 2023 17.53 0.01 0.06% 17.52 17.89 17.29
    May 17, 2023 17.77 0.80 4.71% 16.97 17.86 16.92
    May 16, 2023 17.40 0.25 1.46% 17.15 17.51 17.08
    May 15, 2023 17.58 0.46 2.69% 17.12 17.91 17.03
    May 12, 2023 17.31 -0.11 -0.63% 17.42 17.66 17.09
    May 11, 2023 17.48 -0.12 -0.68% 17.60 18.00 17.38
    May 10, 2023 17.65 0.25 1.44% 17.40 17.84 17.17
    May 9, 2023 17.30 1.25 7.79% 16.05 17.89 15.97

    FibroGen, Inc Events

    Time (UTC) Country Event
    Wednesday, June 7, 2023

    Time (UTC)

    15:00

    Country

    US

    Event

    FibroGen Inc Annual Shareholders Meeting
    FibroGen Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Thursday, June 8, 2023

    Time (UTC)

    18:30

    Country

    US

    Event

    FibroGen Inc at Jefferies Healthcare Conference
    FibroGen Inc at Jefferies Healthcare Conference

    Forecast

    -

    Previous

    -
    Monday, June 12, 2023

    Time (UTC)

    18:20

    Country

    US

    Event

    FibroGen Inc at Goldman Sachs Healthcare Conference
    FibroGen Inc at Goldman Sachs Healthcare Conference

    Forecast

    -

    Previous

    -
    Friday, June 16, 2023

    Time (UTC)

    15:00

    Country

    US

    Event

    FibroGen Inc Annual Shareholders Meeting
    FibroGen Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Monday, August 7, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q2 2023 FibroGen Inc Earnings Release
    Q2 2023 FibroGen Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 6, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q3 2023 FibroGen Inc Earnings Release
    Q3 2023 FibroGen Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 140.734 235.309 176.319 256.577 212.958
    Revenue 140.734 235.309 176.319 256.577 212.958
    Total Operating Expense 441.759 523.839 368.199 345.891 299.651
    Selling/General/Admin. Expenses, Total 127.474 120.557 97.238 126.557 63.812
    Research & Development 296.791 387.043 252.924 209.265 235.839
    Operating Income -301.025 -288.53 -191.88 -89.314 -86.693
    Interest Income (Expense), Net Non-Operating 6.156 -2.153 3.151 12.672 0.577
    Net Income Before Taxes -294.869 -290.683 -188.729 -76.642 -86.116
    Net Income After Taxes -295.227 -291.03 -189.089 -76.97 -86.42
    Net Income Before Extra. Items -293.654 -290.023 -189.291 -76.97 -86.42
    Net Income -293.654 -290.023 -189.291 -76.97 -86.42
    Income Available to Common Excl. Extra. Items -293.654 -290.023 -189.291 -76.97 -86.42
    Income Available to Common Incl. Extra. Items -293.654 -290.023 -189.291 -76.97 -86.42
    Diluted Net Income -293.654 -290.023 -189.291 -76.97 -86.42
    Diluted Weighted Average Shares 93.582 92.349 89.854 86.633 84.062
    Diluted EPS Excluding Extraordinary Items -3.13793 -3.14051 -2.10665 -0.88846 -1.02805
    Diluted Normalized EPS -3.13793 -3.14051 -2.10665 -0.88846 -1.02805
    Total Extraordinary Items
    Cost of Revenue, Total 20.28 12.871 8.869 1.147
    Gross Profit 120.454 222.438 167.45 255.43
    Depreciation / Amortization 0.587 4.639 10.369 10.307
    Other Operating Expenses, Total -3.373 -1.271 -1.201 -1.385
    Equity In Affiliates 1.573 1.007 -0.202
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 36.161 34.367 15.735 29.806 60.827
    Revenue 36.161 34.367 15.735 29.806 60.827
    Cost of Revenue, Total 3.491 4.925 4.308 6.809 4.238
    Gross Profit 32.67 29.442 11.427 22.997 56.589
    Total Operating Expense 112.252 100.519 109.392 108.03 123.82
    Selling/General/Admin. Expenses, Total 34.275 33.966 29.902 30.258 30.564
    Research & Development 74.486 61.628 75.182 70.963 89.018
    Other Operating Expenses, Total
    Operating Income -76.091 -66.152 -93.657 -78.224 -62.993
    Interest Income (Expense), Net Non-Operating -1.336 -0.195 1.714 5.058 -0.419
    Net Income Before Taxes -77.427 -66.347 -91.943 -73.166 -63.412
    Net Income After Taxes -77.501 -66.455 -92.057 -73.189 -63.525
    Equity In Affiliates 0.796 0.28 0.407 0.565 0.32
    Net Income Before Extra. Items -76.705 -66.175 -91.65 -72.624 -63.205
    Net Income -76.705 -66.175 -91.65 -72.624 -63.205
    Income Available to Common Excl. Extra. Items -76.705 -66.175 -91.65 -72.624 -63.205
    Income Available to Common Incl. Extra. Items -76.705 -66.175 -91.65 -72.624 -63.205
    Diluted Net Income -76.705 -66.175 -91.65 -72.624 -63.205
    Diluted Weighted Average Shares 94.691 94.035 93.767 93.475 93.043
    Diluted EPS Excluding Extraordinary Items -0.81006 -0.70373 -0.97742 -0.77694 -0.67931
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.81006 -0.70373 -0.97742 -0.77694 -0.67931
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 492.826 474.059 755.11 702.49 690.015
    Cash and Short Term Investments 422.008 405.19 686.537 533.757 621.402
    Cash 135.819 111.422 88.046 40.715 38.783
    Cash & Equivalents 19.881 59.801 590.347 85.551 50.475
    Short Term Investments 266.308 233.967 8.144 407.491 532.144
    Total Receivables, Net 16.299 25.401 41.883 153.665 63.684
    Accounts Receivable - Trade, Net 28.387 36.331 46.01 158.51 16.474
    Prepaid Expenses 9.73 7.383 8.353 6.464 4.929
    Total Assets 610.087 773.821 826.84 857.397 880.598
    Property/Plant/Equipment, Total - Net 100.933 120.15 65.296 84.276 127.198
    Property/Plant/Equipment, Total - Gross 253.644 252.362 199.305 195.752 192.397
    Accumulated Depreciation, Total -152.711 -132.212 -134.009 -111.476 -65.199
    Long Term Investments 9.409 171.621 2.972 61.118 55.82
    Other Long Term Assets, Total 6.919 7.991 3.462 9.513 7.565
    Total Current Liabilities 273.562 225.497 163.187 102.745 89.033
    Accounts Payable 30.758 26.097 24.789 6.088 9.139
    Accrued Expenses 229.639 180.356 104.384 83.816 66.123
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 13.129 19.033 21.684 0.49 13.771
    Total Liabilities 631.534 564.675 404.662 341.262 371.399
    Total Long Term Debt 17.054 17.616 44.088 55.531 113.955
    Long Term Debt 16.917 17.613 18.697 16.78 16.798
    Capital Lease Obligations 0.137 0.003 25.391 38.751 97.157
    Minority Interest 19.967 19.967 19.271 19.271 19.271
    Other Liabilities, Total 320.951 292.403 169.441 163.715 149.14
    Total Equity -21.447 209.146 422.178 516.135 509.199
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.942 0.929 0.914 0.877 0.854
    Additional Paid-In Capital 1541.02 1476.41 1399.77 1300.72 1226.45
    Retained Earnings (Accumulated Deficit) -1557.69 -1264.03 -974.011 -784.72 -715.827
    Other Equity, Total -5.72 -4.163 -4.499 -0.747 -2.281
    Total Liabilities & Shareholders’ Equity 610.087 773.821 826.84 857.397 880.598
    Total Common Shares Outstanding 94.1661 92.881 91.441 87.657 85.432
    Total Inventory 40.436 31.015 16.53 6.887
    Other Current Assets, Total 4.353 5.07 1.807 1.717
    Current Port. of LT Debt/Capital Leases 0.036 0.011 12.33 12.351
    Deferred Income Tax 9.192 8.675
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 430.549 492.826 474.224 520.643 524.415
    Cash and Short Term Investments 355.949 422.008 408.52 438.133 428.075
    Cash 145.81 135.819 104.509 128.152 165.436
    Cash & Equivalents 42.74 19.881 51.451 39.606 20.46
    Short Term Investments 167.399 266.308 252.56 270.375 242.179
    Total Receivables, Net 17.654 16.299 15.328 33.573 43.883
    Accounts Receivable - Trade, Net 29.217 28.387 29.665 60.352 82.638
    Total Inventory 42.456 40.436 39.95 40.899 43.067
    Prepaid Expenses 14.49 9.73 10.426 8.038 9.39
    Other Current Assets, Total 4.353
    Total Assets 538.544 610.087 608.837 686.789 745.934
    Property/Plant/Equipment, Total - Net 95.367 100.933 105.19 109.159 114.871
    Property/Plant/Equipment, Total - Gross 253.644
    Accumulated Depreciation, Total -152.711
    Long Term Investments 5.884 9.409 22.411 50.414 97.643
    Other Long Term Assets, Total 6.744 6.919 7.012 6.573 9.005
    Total Current Liabilities 254.746 273.562 251.994 240.34 255.374
    Accounts Payable 71.282 30.758 19.323 29.36 36.353
    Accrued Expenses 166.969 229.639 224.577 202.681 211.518
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.036
    Other Current Liabilities, Total 16.495 13.129 8.094 8.299 7.503
    Total Liabilities 587.396 631.534 582.531 583.009 587.886
    Total Long Term Debt 17.276 17.054 15.422 16.439 17.374
    Long Term Debt 17.276 16.917 15.422 16.439 17.374
    Capital Lease Obligations 0.137
    Deferred Income Tax
    Minority Interest 19.967 19.967 19.967 19.967 19.967
    Other Liabilities, Total 295.407 320.951 295.148 306.263 295.171
    Total Equity -48.852 -21.447 26.306 103.78 158.048
    Redeemable Preferred Stock 0 0 0 0
    Common Stock 0.966 0.942 0.939 0.937 0.933
    Additional Paid-In Capital 1589.15 1541.02 1524.23 1509.64 1490.86
    Retained Earnings (Accumulated Deficit) -1634.39 -1557.69 -1491.51 -1399.86 -1327.24
    Other Equity, Total -4.57 -5.72 -7.346 -6.93 -6.505
    Total Liabilities & Shareholders’ Equity 538.544 610.087 608.837 686.789 745.934
    Total Common Shares Outstanding 96.623 94.1661 93.936 93.733 93.289
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -293.654 -290.023 -189.291 -76.97 -86.42
    Cash From Operating Activities -145.933 -82.232 81.602 -78.705 -76.144
    Cash From Operating Activities 10.604 14.809 22.047 21.454 6.562
    Non-Cash Items 66.687 132.899 74.216 62.47 52.112
    Cash Interest Paid 0.104 0.094 0.135 0.174 0.218
    Changes in Working Capital 70.43 60.083 174.63 -85.659 -48.398
    Cash From Investing Activities 89.116 -426.972 452.487 120.018 -522.123
    Capital Expenditures -38.741 -30.186 -3.994 -5.762 -8.02
    Other Investing Cash Flow Items, Total 127.857 -396.786 456.481 125.78 -514.103
    Cash From Financing Activities 46.776 -0.563 13.343 -4.3 13.875
    Financing Cash Flow Items -6.62 -7.372 -11.463 -12.75 -15.612
    Issuance (Retirement) of Stock, Net 53.934 12.701 37.829 20.778 29.847
    Issuance (Retirement) of Debt, Net -0.538 -5.892 -13.023 -12.328 -0.36
    Foreign Exchange Effects -5.482 2.597 4.695 -0.005 -0.008
    Net Change in Cash -15.523 -507.17 552.127 37.008 -584.4
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -76.705 -293.654 -227.479 -135.829 -63.205
    Cash From Operating Activities -101.591 -145.933 -93.42 -41.54 -8.476
    Cash From Operating Activities 2.965 10.604 7.914 5.235 2.584
    Non-Cash Items 18.148 66.687 49.928 34.441 17.77
    Changes in Working Capital -45.999 70.43 76.217 54.613 34.375
    Cash From Investing Activities 103.482 89.116 88.023 43.24 25.935
    Capital Expenditures -0.591 -38.741 -38.408 -37.543 -36.638
    Other Investing Cash Flow Items, Total 104.073 127.857 126.431 80.783 62.573
    Cash From Financing Activities 31.485 46.776 -1.898 -0.806 -2.893
    Financing Cash Flow Items 0 -6.62 -4.562 -3.361 -2.974
    Issuance (Retirement) of Stock, Net 31.657 53.934 2.989 2.779 0.183
    Issuance (Retirement) of Debt, Net -0.172 -0.538 -0.325 -0.224 -0.102
    Foreign Exchange Effects -0.526 -5.482 -7.968 -4.359 0.107
    Net Change in Cash 32.85 -15.523 -15.263 -3.465 14.673
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    PRIMECAP Management Company Investment Advisor 14.4767 14126697 231619 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.0286 8810326 -613439 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2737 6122003 89685 2023-03-31 LOW
    Astellas Pharma Inc Corporation 5.0915 4968367 0 2023-01-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.1772 4076167 -188810 2023-03-31 LOW
    Point72 Asset Management, L.P. Hedge Fund 3.5113 3426427 -1355218 2023-03-31 HIGH
    First Trust Advisors L.P. Investment Advisor 2.7884 2720975 -254678 2023-03-31 LOW
    Baker Bros. Advisors LP Hedge Fund 2.7027 2637384 1262173 2023-03-31 LOW
    Armistice Capital LLC Hedge Fund 2.3693 2312000 -1552000 2023-03-31 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.7703 1727545 70450 2023-03-31 LOW
    Two Sigma Investments, LP Hedge Fund 1.7676 1724909 512435 2023-03-31 HIGH
    Schroder Investment Management North America Inc. Investment Advisor 1.5138 1477161 -246616 2023-03-31 LOW
    Artisan Partners Limited Partnership Investment Advisor 1.3847 1351230 1351230 2023-03-31 LOW
    Assenagon Asset Management S.A. Investment Advisor 1.3779 1344583 1344583 2023-03-31 HIGH
    Jacobs Levy Equity Management, Inc. Investment Advisor/Hedge Fund 1.1877 1159027 -348288 2023-03-31 MED
    Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 1.1157 1088768 593915 2023-03-31 LOW
    Eventide Asset Management, LLC Investment Advisor 0.9838 960000 960000 2023-03-31 MED
    Nuveen LLC Pension Fund 0.9185 896293 328958 2023-03-31 LOW
    Adage Capital Management, L.P. Hedge Fund 0.8711 850000 -1800000 2023-03-31 MED
    Eagle Asset Management, Inc. Investment Advisor/Hedge Fund 0.8488 828307 -74825 2023-03-31 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    535K+

    Trader

    87K+

    Klien aktif per bulan

    $113M+

    Volume investasi per bulan

    $64M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    409 Illinois Street
    SAN FRANCISCO
    CALIFORNIA 94158
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    XRP/USD

    0.53 Price
    +0.500% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00398

    Oil - Crude

    71.53 Price
    -0.010% 1D Chg, %
    Biaya inap posisi Long -0.0179%
    Biaya inap posisi short -0.0040%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    Gold

    1,959.14 Price
    -0.210% 1D Chg, %
    Biaya inap posisi Long -0.0184%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    BTC/USD

    26,815.90 Price
    -0.610% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda